| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |